Home/Filings/4/0001104659-20-079717
4//SEC Filing

SOFINNOVA CAPITAL VI FCPR 4

Accession 0001104659-20-079717

CIK 0001760542other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:16 PM ET

Size

7.0 KB

Accession

0001104659-20-079717

Insider Transaction Report

Form 4
Period: 2020-06-29
Transactions
  • Sale

    Common Stock

    2020-06-29$11.78/sh3,280$38,6283,960,574 total
Transactions
  • Sale

    Common Stock

    2020-06-29$11.78/sh3,280$38,6283,960,574 total
Footnotes (3)
  • [F1]Shares sold pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.

Documents

1 file

Issuer

HOOKIPA Pharma Inc.

CIK 0001760542

Entity typeother
IncorporatedXX

Related Parties

1
  • filerCIK 0001441261

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:16 PM ET
Size
7.0 KB